Neuroprotective effect of preoperatively induced mild hypothermia as determined by biomarkers and histopathological estimation in a rat subdural hematoma decompression model ; Laboratory investigation

Journal of Neurosurgery

Volumn 118, Issue 2, 2013, Pages 370-380

  Yokobori, Shoji ^a,c   Gajavelli, Shyam ^a   Mondello, Stefania ^b,d   Mo Seaney, Jixiang ^b   Bramlett, Helen M ^a   Dalton Dietrich, W ^a   Bullock, M Ross ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b BANYAN BIOMARKERS INC   (United States)

^c NIPPON MEDICAL SCHOOL   (Japan)

^d UNIVERSITY OF FLORIDA   (United States)

Author keywords

Biomarker; Hypothermia; Ischemia reperfusion injury; Microdialysis; Neuronal degeneration; Rat; Traumatic brain injury

Indexed keywords

BIOLOGICAL MARKER; GLIAL FIBRILLARY ACIDIC PROTEIN; UBIQUITIN CARBOXYL TERMINAL HYDROLASE L1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; BRAIN DAMAGE; BRAIN DECOMPRESSION; BRAIN TEMPERATURE; CELL DAMAGE; CONTROLLED STUDY; CRANIOTOMY; GLIA CELL; HISTOPATHOLOGY; HYPOTHERMIA; INDUCED HYPOTHERMIA; MALE; NERVE CELL; NEUROPROTECTION; NONHUMAN; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RAT; SUBDURAL HEMATOMA;

ANIMALS; BIOLOGICAL MARKERS; CELL COUNT; DECOMPRESSION, SURGICAL; DISEASE MODELS, ANIMAL; FLUORESCENT DYES; GLIAL FIBRILLARY ACIDIC PROTEIN; HEMATOMA, SUBDURAL, ACUTE; HYPOTHERMIA, INDUCED; MALE; MICRODIALYSIS; NERVE DEGENERATION; NEUROGLIA; NEURONS; ORGANIC CHEMICALS; PREOPERATIVE CARE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; UBIQUITIN THIOLESTERASE;

EID: 84873693271     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2012.10.JNS12725     Document Type: Article

References (80)

1. Anderson RE, Hansson LO, Nilsson O, Dijlai-Merzoug R, Settergren G: High serum S100B levels for trauma patients without head injuries. Neurosurgery 48:1255-1260, 2001.
2. Arnaoutakis GJ, George TJ, Wang KK, Wilson MA, Allen JG, Robinson CW, et al: Serum levels of neuron-specific ubiquitin carboxyl-terminal esterase-L1 predict brain injury in a canine model of hypothermic circulatory arrest. J Thoracic Cardiovasc Surg 142:902-910, 2011.
3. Becker LB: New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res 61:461- 470, 2004.
4. Bellander BM, Cantais E, Enblad P, Hutchinson P, Nordström CH, Robertson C, et al: Consensus meeting on microdialysis in neurointensive care. Intensive Care Med 30:2166-2169, 2004.
5. Berger RP, Hayes RL, Richichi R, Beers SR, Wang KK: Serum concentrations of ubiquitin C-terminal hydrolase-L1 and II-spectrin breakdown product 145 kDa correlate with outcome after pediatric TBI. J Neurotrauma 29:162-167, 2012.
6. Bloomfield SM, McKinney J, Smith L, Brisman J: Reliability of S100B in predicting severity of central nervous system injury. Neurocrit Care 6:121-138, 2007.
7. Blyth BJ, Farahvar A, He H, Nayak A, Yang C, Shaw G, et al: Elevated serum ubiquitin carboxy-terminal hydrolase L1 is associated with abnormal blood-brain barrier function after traumatic brain injury. J Neurotrauma 28:2453-2462, 2011.
8. Blyth BJ, Farhavar A, Gee C, Hawthorn B, He H, Nayak A, et al: Validation of serum markers for blood-brain barrier disruption in traumatic brain injury. J Neurotrauma 26:1497-1507, 2009.
9. Bolli R, Jeroudi MO, Patel BS, Aruoma OI, Halliwell B, Lai EK, et al: Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial "stunning" is a manifestation of reperfusion injury. Circ Res 65:607-622, 1989.
10. Bramlett HM, Green EJ, Dietrich WD, Busto R, Globus MY, Ginsberg MD: Posttraumatic brain hypothermia provides protection from sensorimotor and cognitive behavioral deficits. J Neurotrauma 12:289-298, 1995.
11. Burger R, Bendszus M, Vince GH, Solymosi L, Roosen K: Neurophysiological monitoring, magnetic resonance imaging, and histological assays confirm the beneficial effects of moderate hypothermia after epidural focal mass lesion development in rodents. Neurosurgery 54:701-712, 2004.
12. Clifton GL, Miller ER, Choi SC, Levin HS, McCauley S, Smith KR Jr, et al: Lack of effect of induction of hypothermia after acute brain injury. N Engl J Med 344:556-563, 2001.
13. Clifton GL, Valadka A, Zygun D, Coffey CS, Drever P, Fourwinds S, et al: Very early hypothermia induction in patients with severe brain injury (the National Acute Brain Injury Study: Hypothermia II): a randomised trial. Lancet Neurol 10:131-139, 2011.
14. Colbourne F, Corbett D: Delayed postischemic hypothermia: a six month survival study using behavioral and histological assessments of neuroprotection. J Neurosci 15:7250-7260, 1995.
15. Colbourne F, Li H, Buchan AM: Indefatigable CA1 sector neuroprotection with mild hypothermia induced 6 hours after severe forebrain ischemia in rats. J Cereb Blood Flow Metab 19:742-749, 1999.
16. Cole TB: Global road safety crisis remedy sought: 1.2 million killed, 50 million injured annually. JAMA 291:2531-2532, 2004.
17. Czeiter E, Mondello S, Kovacs N, Sandor J, Gabrielli A, Schmid K, et al: Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator. J Neurotrauma 29:1770-1778, 2012.
18. Di X, Bullock R: Effect of the novel high-affinity glycine-site N-methyl-D-aspartate antagonist ACEA-1021 on 125I-MK- 801 binding after subdural hematoma in the rat: an in vivo autoradiographic study. J Neurosurg 85:655-661, 1996.
19. Dietrich WD, Alonso O, Busto R, Globus MY, Ginsberg MD: Post-traumatic brain hypothermia reduces histopathological damage following concussive brain injury in the rat. Acta Neuropathol 87:250-258, 1994.
20. Dietrich WD, Bramlett HM: The evidence for hypothermia as a neuroprotectant in traumatic brain injury. Neurotherapeutics 7:43-50, 2010.
21. Erecinska M, Thoresen M, Silver IA: Effects of hypothermia on energy metabolism in Mammalian central nervous system. J Cereb Blood Flow Metab 23:513-530, 2003.
22. Fu ES, Tummala RP: Neuroprotection in brain and spinal cord trauma. Curr Opin Anaesthesiol 18:181-187, 2005.
23. Gunn AJ: Cerebral hypothermia for prevention of brain injury following perinatal asphyxia. Curr Opin Pediatr 12:111-115, 2000.
24. Honda M, Tsuruta R, Kaneko T, Kasaoka S, Yagi T, Todani M, et al: Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase. J Trauma 69: 104-109, 2010.
25. Honeybul S, Ho K, Lind C, Gillett G: Hypothermia in patients with brain injury: the way forward? Lancet Neurol 10:405-406, 2011 (Letter).
26. Janata A, Holzer M: Hypothermia after cardiac arrest. Prog Cardiovasc Dis 52:168-179, 2009.
27. Jia F, Mao Q, Liang YM, Jiang JY: Effect of post-traumatic mild hypothermia on hippocampal cell death after traumatic brain injury in rats. J Neurotrauma 26:243-252, 2009.
28. Jiang JY: Clinical study of mild hypothermia treatment for severe traumatic brain injury. J Neurotrauma 26:399-406, 2009.
29. Jiang JY, Lyeth BG, Clifton GL, Jenkins LW, Hamm RJ, Hayes RL: Relationship between body and brain temperature in traumatically brain-injured rodents. J Neurosurg 74:492- 496, 1991.
30. Johnsson P, Bäckström M, Bergh C, Jönsson H, Lührs C, Alling C: Increased S100B in blood after cardiac surgery is a powerful predictor of late mortality. Ann Thorac Surg 75:162-168, 2003.
31. Jönsson H: S100B and cardiac surgery: possibilities and limitations. Restor Neurol Neurosci 21:151-157, 2003.
32. Karibe H, Zarow GJ, Graham SH, Weinstein PR: Mild intraischemic hypothermia reduces postischemic hyperperfusion, delayed postischemic hypoperfusion, blood-brain barrier disruption, brain edema, and neuronal damage volume after temporary focal cerebral ischemia in rats. J Cereb Blood Flow Metab 14:620-627, 1994.
33. Kawai N, Nakamura T, Okauchi M, Nagao S: Effects of hypothermia on intracranial hemodynamics and ischemic brain damage-studies in the rat acute subdural hematoma model. Acta Neurochir Suppl 76:529-533, 2000.
34. Kawai N, Nakamura T, Okauchi M, Nagao S: Effects of hypothermia on intracranial pressure and brain edema formation: studies in a rat acute subdural hematoma model. J Neurotrauma 17:193-202, 2000.
35. Khalid MA, Ashraf M: Direct detection of endogenous hydroxyl radical production in cultured adult cardiomyocytes during anoxia and reoxygenation. Is the hydroxyl radical really the most damaging radical species? Circ Res 72:725-736, 1993.
36. Kirino T: Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 239:57-69, 1982.
37. Korfias S, Stranjalis G, Boviatsis E, Psachoulia C, Jullien G, Gregson B, et al: Serum S-100B protein monitoring in patients with severe traumatic brain injury. Intensive Care Med 33:255-260, 2007.
38. Kuroda Y, Bullock R: Local cerebral blood flow mapping before and after removal of acute subdural hematoma in the rat. Neurosurgery 30:687-691, 1992.
39. Kwon TH, Chao DL, Malloy K, Sun D, Alessandri B, Bullock MR: Tempol, a novel stable nitroxide, reduces brain damage and free radical production, after acute subdural hematoma in the rat. J Neurotrauma 20:337-345, 2003.
40. Kwon TH, Sun D, Daugherty WP, Spiess BD, Bullock MR: Effect of perfluorocarbons on brain oxygenation and ischemic damage in an acute subdural hematoma model in rats. J Neurosurg 103:724-730, 2005.
41. Langlois JA, Marr A, Mitchko J, Johnson RL: Tracking the silent epidemic and educating the public: CDC's traumatic brain injury-associated activities under the TBI Act of 1996 and the Children's Health Act of 2000. J Head Trauma Rehabil 20:196-204, 2005.
42. Larach DB, Kofke WA, Le Roux P: Potential non-hypoxic/ischemic causes of increased cerebral interstitial fluid lactate/pyruvate ratio: a review of available literature. Neurocrit Care 15:609-622, 2011.
43. Li J, Li XY, Feng DF, Pan DC: Biomarkers associated with diffuse traumatic axonal injury: exploring pathogenesis, early diagnosis, and prognosis. J Trauma 69:1610-1618, 2010.
44. Liu MC, Akinyi L, Scharf D, Mo J, Larner SF, Muller U, et al: Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats. Eur J Neurosci 31: 722-732, 2010.
45. Lumpkins KM, Bochicchio GV, Keledjian K, Simard JM, McCunn M, Scalea T: Glial fibrillary acidic protein is highly correlated with brain injury. J Trauma 65:778-784, 2008.
46. Mar J, Arrospide A, Begiristain JM, Larrañaga I, Elosegui E, Oliva-Moreno J: The impact of acquired brain damage in terms of epidemiology, economics and loss in quality of life. BMC Neurol 11:46, 2011.
47. Marion D, Bullock MR: Current and future role of therapeutic hypothermia. J Neurotrauma 26:455-467, 2009.
48. Massaro F, Lanotte M, Faccani G, Triolo C: One hundred and twenty-seven cases of acute subdural haematoma operated on. Correlation between CT scan findings and outcome. Acta Neurochir (Wien) 138:185-191, 1996.
49. McIntyre LA, Fergusson DA, Hébert PC, Moher D, Hutchison JS: Prolonged therapeutic hypothermia after traumatic brain injury in adults: a systematic review. JAMA 289:2992-2999, 2003.
50. Mondello S, Jeromin A, Buki A, Bullock R, Czeiter E, Kovacs N, et al: Glial neuronal ratio: a novel index for differentiating injury type in patients with severe traumatic brain injury. J Neurotrauma 29:1096-1104, 2012.
51. Mondello S, Linnet A, Buki A, Robicsek S, Gabrielli A, Tepas J, et al: Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury. Neurosurgery 70:666-675, 2012.
52. Neumar RW: Molecular mechanisms of ischemic neuronal injury. Ann Emerg Med 36:483-506, 2000.
53. Nichol AD, Trapani T, Murray L, Vallance S, Cooper DJ: Hypothermia in patients with brain injury: the way forward? Lancet Neurol 10:405, 2011 (Letter).
54. Nielsen TH, Engell SI, Johnsen RA, Schulz MK, Gerke O, Hjelmborg J, et al: Comparison between cerebral tissue oxygen tension and energy metabolism in experimental subdural hematoma. Neurocrit Care 15:585-592, 2011.
55. Okauchi M, Kawai N, Nakamura T, Kawanishi M, Nagao S: Effects of mild hypothermia and alkalizing agents on brain injuries in rats with acute subdural hematomas. J Neurotrauma 19:741-751, 2002.
56. Papa L, Akinyi L, Liu MC, Pineda JA, Tepas JJ III, Oli MW, et al: Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury. Crit Care Med 38: 138-144, 2010.
57. Polderman KH: Mechanisms of action, physiological effects, and complications of hypothermia. Crit Care Med 37 (7 Suppl):S186-S202, 2009.
58. Polderman KH, Andrews PJ: Hypothermia in patients with brain injury: the way forward? Lancet Neurol 10:404-405, 2011 (Letter).
59. Pulsinelli WA, Brierley JB, Plum F: Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol 11:491-498, 1982.
60. Raabe A, Grolms C, Keller M, Döhnert J, Sorge O, Seifert V: Correlation of computed tomography findings and serum brain damage markers following severe head injury. Acta Neurochir (Wien) 140:787-792, 1998.
61. Rosén H, Rosengren L, Herlitz J, Blomstrand C: Increased serum levels of the S-100 protein are associated with hypoxic brain damage after cardiac arrest. Stroke 29:473-477, 1998.
62. Ross SA, Cunningham RT, Johnston CF, Rowlands BJ: Neuron- specific enolase as an aid to outcome prediction in head injury. Br J Neurosurg 10:471-476, 1996.
63. Rundgren M, Karlsson T, Nielsen N, Cronberg T, Johnsson P, Friberg H: Neuron specific enolase and S-100B as predictors of outcome after cardiac arrest and induced hypothermia. Resuscitation 80:784-789, 2009.
64. Savola O, Pyhtinen J, Leino TK, Siitonen S, Niemelä O, Hillbom M: Effects of head and extracranial injuries on serum protein S100B levels in trauma patients. J Trauma 56:1229- 1234, 2004.
65. Shann F: Hypothermia for traumatic brain injury: how soon, how cold, and how long? Lancet 362:1950-1951, 2003.
66. Shao ZH, Sharp WW, Wojcik KR, Li CQ, Han M, Chang WT, et al: Therapeutic hypothermia cardioprotection via Akt- and nitric oxide-mediated attenuation of mitochondrial oxidants. Am J Physiol Heart Circ Physiol 298:H2164-H2173, 2010.
67. Stein DM, Kufera JA, Lindell A, Murdock KR, Menaker J, Bochicchio GV, et al: Association of CSF biomarkers and secondary insults following severe traumatic brain injury. Neurocrit Care 14:200-207, 2011.
68. Svetlov SI, Prima V, Kirk DR, Gutierrez H, Curley KC, Hayes RL, et al: Morphologic and biochemical characterization of brain injury in a model of controlled blast overpressure exposure. J Trauma 69:795-804, 2010.
69. Takeuchi S, Nawashiro H, Otani N: Hypothermia in patients with brain injury: the way forward? Lancet Neurol 10:404, 2011 (Letter).
70. Timmons SD: Current trends in neurotrauma care. Crit Care Med 38 (9 Suppl):S431-S444, 2010.
71. Timofeev I, Carpenter KL, Nortje J, Al-Rawi PG, O'Connell MT, Czosnyka M, et al: Cerebral extracellular chemistry and outcome following traumatic brain injury: a microdialysis study of 223 patients. Brain 134:484-494, 2011.
72. Tuttolomondo A, Di Sciacca R, Di Raimondo D, Arnao V, Renda C, Pinto A, et al: Neuron protection as a therapeutic target in acute ischemic stroke. Curr Top Med Chem 9:1317- 1334, 2009.
73. Vink R, Nimmo AJ: Multifunctional drugs for head injury. Neurotherapeutics 6:28-42, 2009.
74. Voloboueva LA, Suh SW, Swanson RA, Giffard RG: Inhibition of mitochondrial function in astrocytes: implications for neuroprotection. J Neurochem 102:1383-1394, 2007.
75. Vos PE, Jacobs B, Andriessen TM, Lamers KJ, Borm GF, Beems T, et al: GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study. Neurology 75:1786-1793, 2010.
76. Wilberger JE Jr, Harris M, Diamond DL: Acute subdural hematoma: morbidity and mortality related to timing of operative intervention. J Trauma 30:733-736, 1990.
77. Wilberger JE Jr, Harris M, Diamond DL: Acute subdural hematoma: morbidity, mortality, and operative timing. J Neurosurg 74:212-218, 1991.
78. Xu L, Sapolsky RM, Giffard RG: Differential sensitivity of murine astrocytes and neurons from different brain regions to injury. Exp Neurol 169:416-424, 2001.
79. Yang D, Guo S, Zhang T, Li H: Hypothermia attenuates ischemia/ reperfusion-induced endothelial cell apoptosis via alterations in apoptotic pathways and JNK signaling. FEBS Lett 583:2500-2506, 2009.
80. Yokobori S, Watanabe A, Matsumoto G, Onda H, Masuno T, Fuse A, et al: Time course of recovery from cerebral vulnerability after severe traumatic brain injury: a microdialysis study. J Trauma 71:1235-1240, 2011.